Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheidegger

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Nature Communications|February 9, 2022
Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicityCarla Umansky, Agustín E Morellato, Matthias Rieckher, et al.
Medicina|October 11, 2021
[A functional platform to monitor SARS-CoV-2-specific T cell responses in vaccinated individuals and COVID-19 recovered patients]Montana N Manselle Cocco, Florencia Veigas, Camila A Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biologyNadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Nature Communications|February 9, 2022
Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicityCarla Umansky, Agustín E Morellato, Matthias Rieckher, et al.
Medicina|October 11, 2021
[A functional platform to monitor SARS-CoV-2-specific T cell responses in vaccinated individuals and COVID-19 recovered patients]Montana N Manselle Cocco, Florencia Veigas, Camila A Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biologyNadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, et al.
Pageof 4